Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 22 November, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo

JHS Svendgaard Laboratories Ltd: Intrinsic Value and Fundamental Analysis

Share Price and Basic Stock Data

Last Updated: November 21, 2024, 9:58 pm

Market Cap 167 Cr.
Current Price 21.4
High / Low39.5/15.5
Stock P/E
Book Value 23.2
Dividend Yield0.00 %
ROCE1.69 %
ROE2.36 %
Face Value 10.0
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for JHS Svendgaard Laboratories Ltd

Competitors of JHS Svendgaard Laboratories Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Honasa Consumer Ltd 7,731 Cr. 238547/237102 35.50.00 %17.1 %% 10.0
Ambica Agarbathies Aroma & Industries Ltd 51.2 Cr. 29.943.2/23.234.2 60.60.00 %5.07 %3.65 % 10.0
Ador Multi Products Ltd 15.1 Cr. 32.345.9/30.1 23.20.00 %33.6 %26.7 % 10.0
Kaya Ltd 460 Cr. 348702/267 1060.00 %80.4 %% 10.0
Jyothy Labs Ltd 14,885 Cr. 405596/36739.6 51.40.86 %27.0 %21.2 % 1.00
Industry Average72,450.14 Cr2,175.3453.02103.770.70%36.77%29.68%4.94

All Competitor Stocks of JHS Svendgaard Laboratories Ltd

Quarterly Result

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales31.6726.9425.3821.5924.6420.9119.1121.3121.0525.4525.4015.9018.93
Expenses28.7225.1225.3322.2923.5022.0519.2522.7723.0227.2828.2518.0218.52
Operating Profit2.951.820.05-0.701.14-1.14-0.14-1.46-1.97-1.83-2.85-2.120.41
OPM %9.31%6.76%0.20%-3.24%4.63%-5.45%-0.73%-6.85%-9.36%-7.19%-11.22%-13.33%2.17%
Other Income0.440.764.392.581.692.742.381.482.521.67-10.820.410.20
Interest0.300.300.310.240.270.270.610.680.120.250.390.130.10
Depreciation1.901.841.621.791.861.711.691.701.491.712.311.321.50
Profit before tax1.190.442.51-0.150.70-0.38-0.06-2.36-1.06-2.12-16.37-3.16-0.99
Tax %26.05%75.00%-13.15%-80.00%34.29%92.11%-7,300.00%-75.85%13.21%1.89%38.12%18.35%26.26%
Net Profit0.890.112.85-0.290.47-0.02-4.44-4.16-0.92-2.08-10.12-2.59-0.73
EPS in Rs0.160.020.41-0.040.040.04-0.67-0.59-0.14-0.24-1.52-0.40-0.11

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales127603555100104140124139101869675
Expenses1104839599392126124137998710579
Operating Profit1612-4-471214022-1-9-5
OPM %13%20%-11%-7%7%11%10%0%1%2%-1%-9%-6%
Other Income112-3-6-170326379-4-8
Interest610140011121111
Depreciation71415121067797777
Profit before tax30-35-22-22538-2-610-22-20
Tax %66%1,357%18%-0%0%-327%32%19%17%-39%4,000%23%
Net Profit1-4-29-22-222226-2-51-4-17-13
EPS in Rs0.63-1.56-11.95-9.20-5.764.984.29-0.11-0.330.19-0.62-2.38-2.01
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2012-20132013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-2023
YoY Net Profit Growth (%)-500.00%-625.00%24.14%0.00%200.00%18.18%-107.69%-150.00%120.00%-500.00%-325.00%
Change in YoY Net Profit Growth (%)0.00%-125.00%649.14%-24.14%200.00%-181.82%-125.87%-42.31%270.00%-620.00%175.00%

JHS Svendgaard Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:-11%
3 Years:-11%
TTM:2%
Compounded Profit Growth
10 Years:6%
5 Years:%
3 Years:%
TTM:-735%
Stock Price CAGR
10 Years:11%
5 Years:7%
3 Years:-3%
1 Year:-19%
Return on Equity
10 Years:0%
5 Years:0%
3 Years:-1%
Last Year:-2%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 10:31 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital24242438446161616465787886
Reserves6538965786113116117124121959196
Borrowings10154193227976354
Other Liabilities41743325233239553330522222
Total Liabilities232190171122155208223241228222228197208
Fixed Assets13512110865657171666359659090
CWIP00011157920912
Investments000011810624334
Other Assets9770635789118137163154140152102112
Total Assets232190171122155208223241228222228197208

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +60287-4-414-111012-923-9
Cash from Investing Activity +-22311-3-27-7-11-2-510-22
Cash from Financing Activity +-39-29-104101413010-2-12
Net Cash Flow-22-1230-5-020-1632-28

Free Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Free Cash Flow16.00-89.00-58.00-23.004.0010.0012.00-7.00-7.00-5.00-7.00-12.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days220.26188.40167.2625.3247.86111.17158.41252.28212.6576.6879.7966.40
Inventory Days132.09121.7894.3253.4694.6764.7259.9130.2097.08114.39128.31176.64
Days Payable407.4095.09105.7166.63123.37152.98133.71177.37128.11129.66197.15196.73
Cash Conversion Cycle-55.04215.09155.8812.1519.1622.9284.61105.11181.6361.4110.9546.31
Working Capital Days28.91-367.5984.2658.8456.41122.23187.28201.96277.49221.6243.0471.81
ROCE %1.01%-9.56%-12.05%-2.76%5.06%7.85%-0.18%3.51%1.04%0.73%-2.04%-1.69%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters41.77%41.77%41.77%42.23%42.23%42.23%42.23%42.23%42.23%37.73%37.73%37.73%
FIIs0.39%0.00%0.04%0.18%0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.29%
DIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%9.16%6.21%
Public57.84%58.23%58.20%57.59%57.77%57.77%57.78%57.78%57.78%62.25%53.10%53.75%
No. of Shareholders21,81725,37325,15524,75424,31724,30524,30823,96523,80022,79422,64826,448

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)-0.52-2.34-0.630.20-0.32
Diluted EPS (Rs.)-0.52-2.34-0.630.20-0.32
Cash EPS (Rs.)0.29-1.430.421.330.64
Book Value[Excl.RevalReserv]/Share (Rs.)21.6727.7830.0530.7430.31
Book Value[Incl.RevalReserv]/Share (Rs.)21.6727.7830.0530.7430.31
Revenue From Operations / Share (Rs.)9.0314.8213.2915.6522.84
PBDIT / Share (Rs.)0.430.811.321.472.55
PBIT / Share (Rs.)-0.37-0.330.230.341.11
PBT / Share (Rs.)-0.43-3.370.010.15-0.95
Net Profit / Share (Rs.)-0.51-2.58-0.660.20-0.79
NP After MI And SOA / Share (Rs.)-0.51-2.38-0.620.18-0.32
PBDIT Margin (%)4.775.509.919.3911.14
PBIT Margin (%)-4.19-2.251.732.194.84
PBT Margin (%)-4.84-22.700.110.96-4.20
Net Profit Margin (%)-5.73-17.43-4.971.33-3.48
NP After MI And SOA Margin (%)-5.73-16.07-4.691.18-1.42
Return on Networth / Equity (%)-2.38-8.96-2.170.63-1.11
Return on Capital Employeed (%)-1.70-1.090.731.073.50
Return On Assets (%)-2.05-6.54-1.820.52-0.82
Total Debt / Equity (X)0.020.000.000.000.00
Asset Turnover Ratio (%)0.320.410.360.420.59
Current Ratio (X)1.872.364.185.232.69
Quick Ratio (X)1.332.003.544.732.57
Inventory Turnover Ratio (X)3.114.365.168.9415.68
Interest Coverage Ratio (X)7.345.096.137.637.94
Interest Coverage Ratio (Post Tax) (X)-7.822.78-2.082.083.96
Enterprise Value (Cr.)121.6970.51136.74117.0751.74
EV / Net Operating Revenue (X)1.720.731.591.160.37
EV / EBITDA (X)36.0313.3115.9912.373.34
MarketCap / Net Operating Revenue (X)1.811.061.551.270.32
Price / BV (X)0.750.590.710.680.25
Price / Net Operating Revenue (X)1.811.061.551.270.32
EarningsYield-0.03-0.15-0.030.01-0.04

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of JHS Svendgaard Laboratories Ltd as of November 22, 2024 is: 8.38

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 22, 2024, JHS Svendgaard Laboratories Ltd is Overvalued by 60.84% compared to the current share price 21.40

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of JHS Svendgaard Laboratories Ltd as of November 22, 2024 is: 6.88

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 22, 2024, JHS Svendgaard Laboratories Ltd is Overvalued by 67.85% compared to the current share price 21.40

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -17.89%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has higher reserves (93.46 cr) compared to borrowings (17.08 cr), indicating strong financial stability.
  1. The stock has a low average ROCE of -0.76%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 82.19, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 71.68, which may not be favorable.
  4. The company has not shown consistent growth in sales (95.54) and profit (-6.31).

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in JHS Svendgaard Laboratories Ltd:
    1. Net Profit Margin: -5.73%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: -1.7% (Industry Average ROCE: 36.77%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: -2.38% (Industry Average ROE: 29.68%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): -7.82
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.33
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 0 (Industry average Stock P/E: 53.02)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.02
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

JHS Svendgaard Laboratories Ltd. is a Public Limited Listed company incorporated on 08/10/2004 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L74110HP2004PLC027558 and registration number is 027558. Currently company belongs to the Industry of Personal Care. Company’s Total Operating Revenue is Rs. 79.91 Cr. and Equity Capital is Rs. 64.90 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Personal CareTrilokpur Road, Kheri (Kala Amb), Sirmour Dist. Himachal Pradesh 173030cs@svendgaard.com
http://www.svendgaard.com
Management
NamePosition Held
Mr. Rajagopal Chakravarthi VenkateishChairman & Ind.Director
Mr. Nikhil NandaManaging Director
Mr. Vinay MittalNon Executive Director
Mr. Mukul PathakIndependent Director
Mr. Kapil MinochaIndependent Director
Mrs. Upma ChawdhryIndependent Woman Director

FAQ

What is the latest intrinsic value of JHS Svendgaard Laboratories Ltd?

The latest intrinsic value of JHS Svendgaard Laboratories Ltd as on 22 November 2024 is ₹8.38, which is 60.84% lower than the current market price of ₹21.40.

What is the Market Cap of JHS Svendgaard Laboratories Ltd?

The Market Cap of JHS Svendgaard Laboratories Ltd is 167 Cr..

What is the current Stock Price of JHS Svendgaard Laboratories Ltd as on 22 November 2024?

The current stock price of JHS Svendgaard Laboratories Ltd as on 22 November 2024 is 21.4.

What is the High / Low of JHS Svendgaard Laboratories Ltd stocks in FY 2024?

In FY 2024, the High / Low of JHS Svendgaard Laboratories Ltd stocks is 39.5/15.5.

What is the Stock P/E of JHS Svendgaard Laboratories Ltd?

The Stock P/E of JHS Svendgaard Laboratories Ltd is .

What is the Book Value of JHS Svendgaard Laboratories Ltd?

The Book Value of JHS Svendgaard Laboratories Ltd is 23.2.

What is the Dividend Yield of JHS Svendgaard Laboratories Ltd?

The Dividend Yield of JHS Svendgaard Laboratories Ltd is 0.00 %.

What is the ROCE of JHS Svendgaard Laboratories Ltd?

The ROCE of JHS Svendgaard Laboratories Ltd is 1.69 %.

What is the ROE of JHS Svendgaard Laboratories Ltd?

The ROE of JHS Svendgaard Laboratories Ltd is 2.36 %.

What is the Face Value of JHS Svendgaard Laboratories Ltd?

The Face Value of JHS Svendgaard Laboratories Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in JHS Svendgaard Laboratories Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE